Posters

Safety and efficacy of combined transscleral micropulse diode laser cyclocoagulation with phacoemulsification and intraocular lens implantation

Poster Details

First Author: O.Parkhomenko UKRAINE

Co Author(s):    G. Parkhomenko   O. Parkhomenko   A. Kovalenko              

Abstract Details

Purpose:

To evaluate safety and efficacy of combined surgery of contact transscleral micropulse diode laser cyclocoagulation (CTMDLC) with phacoemulsification and intraocular lens (IOL) implantation in patients with cataract and glaucoma.

Setting:

Medical center "New Vision", Kyiv, Ukraine

Methods:

In 25 patients (25 eyes) with nonmature cataract and noncompensated primary open angle glaucoma simultaneous procedure of CTMDLC (31,3% duty cycle) and phacoemulsification with IOL implantation was performed. An operation was considered successful when the postoperative IOP remained between 5 and 21 mmHg and was reduced 30% from baseline IOP with or without medication, there was no loss of visual acuity after surgery or vision-threatening severe complications. Preoperational IOP was 25,5±2 mmHg. Average preoperational quantity of antiglaucomatous medicine used was 2,6. The peculiarity of combined surgery was performing of epibulbar and intracameral anesthesia without retrobulbar block before cyclocoagulation procedure.

Results:

Combined surgery of CTMDLC with phacoemulsification and IOL implantation was carried our without complications and was successful in 21 eyes (84%) in terms of 2 months after surgery and 20 eyes (80%) in terms of 6 months. Postoperational IOP was 14,5±2 mm Hg and was reduced on average 56% from baseline. Average postoperational quantity of antiglaucomatous medcine used was 1,3. Six eyes (24%) needed  one additional CTMDLC procedure to achieve target IOP and 5 eyes undergone filtering glaucoma surgery.

Conclusions:

Combined procedure of transscleral micropulse diode laser cyclocoagulation with phacoemulsification and intraocular lens implantation allows to achieve acceptable IOP reduction level effectively without vision-threatening severe complications in most cases in short term after surgery. Further investigation of long-term efficacy and safety of combined procedure of CTMDLC and  phacoemulsification and IOL implantation have to be established.

Financial Disclosure:

None